Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
The podcast can be downloaded here and is embedded below. Subscribe to the podcast via Apple Podcast, Google Play, Spotify or the RSS feed. Updates on the podcast on Twitter at @Lawbytespod.
Credits:
CTV News, Canada’s Chief Public Health Officer Says a Coronavirus Vaccine is ‘Probably’ a Year Away
As countries around the globe work to get their citizen vaccinated against COVID-19, a battle over intellectual property rules has emerged at the World...
Since the introduction of Bill C-11, Canadian Heritage Minister Pablo Rodriguez has insisted that he heard the concerns about regulating user generated content and...
Questions about trust in the media have escalated in Canada in recent months as with each error or questionable tweet, there is seemingly an...